In this study, using gene expression profiling to decipher differences between BLS-type DLBCL and conventional DLBCL (not otherwise specified, NOS), we report here that BLS-type DLBCL has higher expression of the stem cell markers HOXA9 and NANOG. Here, HOXA9 is linked to diffuse large B-cell lymphoma.